Back to search results

Improving Colorectal Cancer Screening for Older Adults

This study aims to improve how doctors decide about colorectal cancer screening for adults over 75. Researchers are developing a special computer tool (a "Decision Tool") that will appear in a doctor's electronic health record. This tool will advise doctors if screening might not be recommended for patients whose life expectancy (how long someone is expected to live) is less than 10 years. The study will test this tool to see if it helps doctors make screening decisions that match a patient's life expectancy. The goal is to make sure colonoscopies are ordered appropriately for older adults. This study plans to include 15,000 participants.

Study design
This is an interventional study, meaning it tests a specific intervention (the Decision Tool). It aims to enroll 15,000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, life-expectancy congruent colonoscopy ordering, is measured at 7 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07141901

Life Expectancy-informed Colorectal Cancer Screening

Not Yet Recruiting
NAAges 76+InterventionalScreening
Kathryn Martinez
~15,000 participants
Updated 2025-09-24 on ClinicalTrials.gov
What's tested:Decision Tool

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Life-expectancy congruent colonoscopy ordering at the clinic level
Measured over 7 days

Conditions

Colorectal Cancer Control and Prevention

Explore related trials

Colorectal Carcinoma

Where it's being run

1 sites across 1 states
Ohio1

Study leadership

  • Kathryn Martinez, PhD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic

Who to contact

Kathryn Martinez, PhD
[email protected]
216 636-0673
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

\> 75 years of age
Resident of Ohio
Had at least one Internal Medicine or Family Medicine visit at Cleveland Clinic Health System between January 1, 2007, and September 1, 2022.
Internal Medicine or Family Medicine clinician (MD, DO, or APP) practicing at Cleveland Clinic Health System in Northeast Ohio
Saw ≥10 study-eligible patients, defined as patients aged \>75 years who were due or overdue for colorectal cancer screening, between 2024-2025
With a colonoscopy ordering rate for patients \>75 years in either the top quarter of the distribution of all eligible clinicians or bottom quarter of all eligible clinicians
Currently practicing in Internal or Family Medicine as an attending clinician
Saw ≥10 study-eligible patients, defined as patients aged \>75 years who were due or overdue for colorectal cancer screening, between 2024-2025
\>75 years of age
Have not received a colonoscopy in the prior 10 years
Have not received a FOBT/FIT in prior year
Had a visit in Internal Medicine or Family Medicine between January 1, 2026 and January 1, 2028

Exclusion

Patients aged ≤75 years
Patients who did not have at least one subsequent Internal or Family Medicine visit in Ohio within two years from the date of their baseline visit
Patients being actively treated for non-skin cancer
Clinicians who are not in the top or bottom quarter of the distribution of colonoscopy orderers for patients aged \>75 years
Trainees/residents
Saw \<10 study-eligible patients between 2024-2025
Patients aged \<75 years
Patients up to date with colorectal cancer screening (colonoscopy within 10 years or FOBT/FIT/Cologuard within the past year)

What this trial measures

  • Life-expectancy congruent colonoscopy ordering at the clinic level7 days

    The investigators will define this separately for patients with \<10 years life expectancy and those with ≥10 years life expectancy. For both groups, the investigators will assess the proportion who received an order for colonoscopy versus not. The investigators hypothesize the intervention will result in more life expectancy-appropriate ordering: for those in the \<10-year life expectancy group, the intervention will be associated with a lower ordering rate, while in the ≥10-year life expectancy group, the intervention will be associated with a higher ordering rate. The investigators will measure colonoscopy orders within 7 days of their index visit.